Sign in

CIK 0001607678

  • Large accelerated filer

Viking Therapeutics, Inc.

Sign in to watch
Ticker
VKTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
461073877
Phone
+1 858-704-4660
Business address
9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
  1. 4 Open-market sale President & CEO sold 38,989 shares at $35.01 ($1,364,923)
  2. 4 Open-market sale Chief Financial Officer sold 6,185 shares at $35.00 ($216,481)
  3. 4 Open-market sale President & CEO sold 26,889 shares at $27.80 ($747,633)
  4. 4 Open-market sale Chief Financial Officer sold 4,266 shares at $27.76 ($118,428)
  5. 4 Open-market sale Chief Operating Officer sold 4,266 shares at $27.77 ($118,473)
  6. 4 Exercise or conversion Director acquired 20,786 shares (option exercise)
  7. 4/A Open-market buy Director bought 1,240 shares at $24.15 ($29,943)
  8. 4 Open-market buy Director bought 1,240 shares at $24.15 ($29,943)
  9. 4 Open-market sale President & CEO sold 194,490 shares at an average $42.75 ($8,313,601)
  10. 4 Open-market sale Chief Operating Officer sold 54,215 shares at an average $42.75 ($2,317,599)
  11. 4 Open-market sale Chief Financial Officer sold 50,309 shares at an average $42.75 ($2,150,595)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market sale Director sold 2,000 shares at $68.67 ($137,333)
  18. 4 Planned sale Chief Financial Officer sold 131,687 shares at an average $76.61 ($10,089,164)
  19. 4 Planned sale Director sold 11,000 shares at $80.89 ($889,790)
  20. 4 Planned sale Director sold 16,000 shares at $79.50 ($1,272,000)

Page 2 of 11 · 216 filings